lost in pennyland
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice large end of the day buy at the ask of .09. We're overdue for that MAA filing. I think we'll be moving a lot higher once that is in.
A $90,000 or so bet for a stock that has been silent for a few months. It has me reaching for more funds.
What was the all-time high on ACUS. I seem to remember it trading in the $5.00 range a few years ago...
The website has been updated. The content hasn't changed much, but the look is sharper. Looks good. Let the sales begin...
What reason do you have to believe that MCET has a drug that inhibits the expression of the STAT3 gene?
No, that's not it...
Not likely worth anything. It's a hail mary.
Fully diluted the market cap is $12,000,000. If tesetaxel actually worked as well as the other taxanes, this would be undervalued. But even if Tesetaxel became the taxane of choice, Genta would need a lot more financing to fund the trials.
Way too much risk here, but genta always seems to run 5x to 10x at some point. It probably will again soon. Looks like it's finally bottoming out.
I just saw that Chris Jesus Ferguson and Howard Lederer were busted for taking $440 million from their Full Tilt Poker clients.
That pretty much sums up Genta and to some extent, the stock market in general. The deck is stacked against the public, the ones who are funding these ventures.
It's a chart joke based on Genta's 20 year chart, which in itself is absurdist humor. I love Genta, it was my first love on the stock market.
And now it is such a classic piece of art. A living, breathing ode to everything that is wrong with the world. And it just keeps digging deeper every day.
January 1993, I remember it like it was yesterday...
I had just amassed a fortune of 150 billion dollars making one winning trade after another in the emerging field of personal computers and semiconductors. I thought of kicking back and retiring, but I decided that I was going to try to become the first trillionaire. So after countless hours of due diligence, I decided that the potential in biotechnology was enormous and that was where I would make my trillions.
On the day I decided to invest, I read in the Wall Street Journal that a biotech out of New Jersey was going public with a new technology called antisense. That company was Genta Inc. I felt that it was fate that I had come across this undiscovered gem on the day I was going to invest in biotechnology and decided to go all in.
The rest, as they say, is history. My $150 billion has dwindled to one dollar and 90 cents as the company lost millions trying to develop genasense. Eighteen years later, genasense has failed and Genta is now clinging to the hope that oral taxol will succeed in clinical trials. I know it's crazy but I still believe I'll make a trillion on my investment in Genta. It might take a while longer than I had originally planned, but I still believe.
I STILL BELIEVE!
Heard a great piece on the solar industry this week. The Chinese government is heavily subsidizing it's solar companies and China has become the world leader in the industry that we invented. The U.S. only accounts for a miniscule 7% of the market.
But China's companies are selling old technology products while U.S. companies are trying to innovate and overcome the material costs to get more competitive (re ENSL). Of the current industry leaders in the US, one company just lost a boatload of money, and the other (firstsolar?) isn't exactly thriving.
The Obama administration gave a big donor's company half a billion dollars, and the company subsequently just filed for bankruptcy.
I know a company that has a backer with billions in cash and a technology that may reduce costs to the point that it is competitive in producing electricity. They also own a lot of land in the desert.
Added WOLV, CSBR, AAVG, BMOD, IRBS and IFRS to the mistake list. I think the four remaining give me the best chance for success as long-term holds.
Our quiet little stock continues to sit still. Not a dog, just a puppy.
Sure looks to me like we could see an ACTC-like move. Not that MCET is in their league yet, but all it takes is one blockbuster drug candidate to move to a much higher zip code...
.0005 is half of .001, so he would be buying at a 50% discount to his predicted low. Not likely to happen...
MCET is a fully reporting company to the securities and exchange commission. So you don't have to go running to the TA every five minutes to find out what their OS is. Just read the quarterly report.
Added MCET to the longshot list.
I sold out around the time they did the reverse merger. I haven't paid much attention since then, but I see they issued a PR today stating that they will be presenting at the Rodman and Renshaw annual global conference in New York. CEO Edward Cappabianca will be presenting Tuesday Sept. 13 at 3:40 pm.
Volume upticking slightly and up another one-tenth of a penny to .0699. Up two weeks in a row - we're on a winning steak!
The news was very good this week. Certification of the SolarVolt product.
Hmmm, up on heavier than usual volume the last two days. I think this is starting to come together a little bit...
This is the biggie. They nail this product, we're golden...
http://www.entechsolar.com/press-releases-details.php?id=176
Still waiting... up one-tenth of a cent to .069. Things are coming together behind the scenes, I just know it.
Oops I hastely read the e-mail to say they had been engaged since Dec 31 2010. After re-reading it I see it said that as of today they are engaged to audit the Dec 31, 2010 financials.
So I'm not sure how long ACSB has been working on the audit of the 2010 financials.
Added ACUS to the longshot list.
Yes the e-mail said that they have been engaged since December 31, 2010. Hopefully that means soon. I don't know how long audits generally take.
As the e-mail says, biopharm hired ACSB to audit them December 31 of 2010. Hopefully that means we're due for an audit very soon, but Maurice wouldn't give me a timetable. He said that was against the rules.
http://www.acsbco.com/
He's the B in ACSB - the accounting firm hired by Biopharm to audit them.
As of August 17, 2011 we have been engaged to audit the December 31 2010 financial statements of Biopharm Asia, Inc. and Subsidiaries.
Maurice Berkower
I just received this email a few minutes ago. Isn't this a green light to buy? If the numbers weren't true, would BFAR have hired ACSB to audit their financials?
This looks like the guy...Hmmm
http://www.donobi.com/about/directors/bill_wright.php
Maybe we're focusing (pun intended) on the wrong subsidiary. Where's Bill getting all the cash to buy these subsidiaries?
What do we know about Mr. William M Wright III? Seems to have a decent stockpile of cash for starters...
http://www.sec.gov/Archives/edgar/data/1418115/000109230610000238/ex10-1.htm
I didn't know that there was an issue with distribution. Where did you see that? I thought it was just the audit holding us up.
What is the cost basis of your five million shares?
Okay that will be great.
You should sticky that post...and take over the mod position while you're at it.
Impressive company, I can see what attracted David Gelbaum to this company more than any of the other green companies he invested in. They've worked with NASA and the DOD. ENSL has solar panels in outer space.
I expect them sooner than that, but I bet Mikey and burp know more about it than I do.
You always have to dig a little deeper in the pennies to find the catch. The catch here is, Aqualiv isn't using conventional bioinformatics to create their products. If anyone can explain in layman's terms how they are creating their products, please do so.
I'm not saying their products aren't legitimate, but I will say this is a form of bioinformatics not used in the United States.
Apparently, like the natural sweetner stevia, this kind of science has been used in Japan for 30 or 40 years, which coincides with the career of our esteemed "father of bioinformatics."
Could be something revolutionary, let's hope...
Yes if they get audited financials that prove that their numbers were accurate this will go to dollars.
The last time they put out "audited financials" it went over $6.00 a share, and the OS has changed little if any since then.
I wonder if someone who has been a shareholder longer than I can answer a question that has crossed my mind a couple of times when reading up on ENSL.
Why did ENSL decide to go public through WWAT? Was there any synergy between the two companies, or did the WWAT business completely disappear when ENSL was merged in?